Differential device performances for hepatic arterial chemotherapy: A technical report on totally implantable pumps and ports for both continuous and bolus infusion

D. Civalleri, F. DeCian, R. Pellicci, Nadia Balletto, G. Simoni, M. Cosimelli, G. Mondini, Paola Bignami, P. P. Cagol

Research output: Contribution to journalArticle

Abstract

Performances of totally implantable infusion systems were analyzed in patients with colorectal liver metastases undergoing intra-arterial treatment. It consisted of 14-day continuous infusion of 5-fluor-2'deoxyuridine with pumps (pump14, 44 patients) or ports fed by external pumps (port14, 34 patients), or bolus infusion of cisplatin (port21, 57 patients) or epirubicin (port7, 22 patients) every 3rd week and weekly, respectively. Toxicity and disease progression were the most common causes of treatment interruption. System failure occurred in 2 pump14, 9 port14, 6 port21 and 2 port7 cases. Pocket problems were most frequent in the pump14 group (30%), whereas catheter- and infusion-related problems were mostly observed in the port14 group (109%). The devices were still functional after 12 months in 92% of pump14, 24% of port14, 65% of port21 and in 78% of port7 patients. Although implantable ports allow adequate infusion periods, in most cases they appear especially suitable for bolus infusions.

Original languageEnglish
Pages (from-to)26-33
Number of pages8
JournalEuropean Surgical Research
Volume30
Issue number1
DOIs
Publication statusPublished - Jan 1998

Fingerprint

Drug Therapy
Equipment and Supplies
Liver
Epirubicin
Deoxyuridine
Cisplatin
Disease Progression
Catheters
Neoplasm Metastasis
Therapeutics

Keywords

  • Colorectal neoplasms
  • Implantable devices
  • Infusion pumps
  • Infusions, intra-arterial
  • Liver neoplasms

ASJC Scopus subject areas

  • Surgery

Cite this

Differential device performances for hepatic arterial chemotherapy : A technical report on totally implantable pumps and ports for both continuous and bolus infusion. / Civalleri, D.; DeCian, F.; Pellicci, R.; Balletto, Nadia; Simoni, G.; Cosimelli, M.; Mondini, G.; Bignami, Paola; Cagol, P. P.

In: European Surgical Research, Vol. 30, No. 1, 01.1998, p. 26-33.

Research output: Contribution to journalArticle

Civalleri, D. ; DeCian, F. ; Pellicci, R. ; Balletto, Nadia ; Simoni, G. ; Cosimelli, M. ; Mondini, G. ; Bignami, Paola ; Cagol, P. P. / Differential device performances for hepatic arterial chemotherapy : A technical report on totally implantable pumps and ports for both continuous and bolus infusion. In: European Surgical Research. 1998 ; Vol. 30, No. 1. pp. 26-33.
@article{cb558fe316344d0783dfdd76332bcb6a,
title = "Differential device performances for hepatic arterial chemotherapy: A technical report on totally implantable pumps and ports for both continuous and bolus infusion",
abstract = "Performances of totally implantable infusion systems were analyzed in patients with colorectal liver metastases undergoing intra-arterial treatment. It consisted of 14-day continuous infusion of 5-fluor-2'deoxyuridine with pumps (pump14, 44 patients) or ports fed by external pumps (port14, 34 patients), or bolus infusion of cisplatin (port21, 57 patients) or epirubicin (port7, 22 patients) every 3rd week and weekly, respectively. Toxicity and disease progression were the most common causes of treatment interruption. System failure occurred in 2 pump14, 9 port14, 6 port21 and 2 port7 cases. Pocket problems were most frequent in the pump14 group (30{\%}), whereas catheter- and infusion-related problems were mostly observed in the port14 group (109{\%}). The devices were still functional after 12 months in 92{\%} of pump14, 24{\%} of port14, 65{\%} of port21 and in 78{\%} of port7 patients. Although implantable ports allow adequate infusion periods, in most cases they appear especially suitable for bolus infusions.",
keywords = "Colorectal neoplasms, Implantable devices, Infusion pumps, Infusions, intra-arterial, Liver neoplasms",
author = "D. Civalleri and F. DeCian and R. Pellicci and Nadia Balletto and G. Simoni and M. Cosimelli and G. Mondini and Paola Bignami and Cagol, {P. P.}",
year = "1998",
month = "1",
doi = "10.1159/000008554",
language = "English",
volume = "30",
pages = "26--33",
journal = "European Surgical Research",
issn = "0014-312X",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Differential device performances for hepatic arterial chemotherapy

T2 - A technical report on totally implantable pumps and ports for both continuous and bolus infusion

AU - Civalleri, D.

AU - DeCian, F.

AU - Pellicci, R.

AU - Balletto, Nadia

AU - Simoni, G.

AU - Cosimelli, M.

AU - Mondini, G.

AU - Bignami, Paola

AU - Cagol, P. P.

PY - 1998/1

Y1 - 1998/1

N2 - Performances of totally implantable infusion systems were analyzed in patients with colorectal liver metastases undergoing intra-arterial treatment. It consisted of 14-day continuous infusion of 5-fluor-2'deoxyuridine with pumps (pump14, 44 patients) or ports fed by external pumps (port14, 34 patients), or bolus infusion of cisplatin (port21, 57 patients) or epirubicin (port7, 22 patients) every 3rd week and weekly, respectively. Toxicity and disease progression were the most common causes of treatment interruption. System failure occurred in 2 pump14, 9 port14, 6 port21 and 2 port7 cases. Pocket problems were most frequent in the pump14 group (30%), whereas catheter- and infusion-related problems were mostly observed in the port14 group (109%). The devices were still functional after 12 months in 92% of pump14, 24% of port14, 65% of port21 and in 78% of port7 patients. Although implantable ports allow adequate infusion periods, in most cases they appear especially suitable for bolus infusions.

AB - Performances of totally implantable infusion systems were analyzed in patients with colorectal liver metastases undergoing intra-arterial treatment. It consisted of 14-day continuous infusion of 5-fluor-2'deoxyuridine with pumps (pump14, 44 patients) or ports fed by external pumps (port14, 34 patients), or bolus infusion of cisplatin (port21, 57 patients) or epirubicin (port7, 22 patients) every 3rd week and weekly, respectively. Toxicity and disease progression were the most common causes of treatment interruption. System failure occurred in 2 pump14, 9 port14, 6 port21 and 2 port7 cases. Pocket problems were most frequent in the pump14 group (30%), whereas catheter- and infusion-related problems were mostly observed in the port14 group (109%). The devices were still functional after 12 months in 92% of pump14, 24% of port14, 65% of port21 and in 78% of port7 patients. Although implantable ports allow adequate infusion periods, in most cases they appear especially suitable for bolus infusions.

KW - Colorectal neoplasms

KW - Implantable devices

KW - Infusion pumps

KW - Infusions, intra-arterial

KW - Liver neoplasms

UR - http://www.scopus.com/inward/record.url?scp=0031975727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031975727&partnerID=8YFLogxK

U2 - 10.1159/000008554

DO - 10.1159/000008554

M3 - Article

C2 - 9493691

AN - SCOPUS:0031975727

VL - 30

SP - 26

EP - 33

JO - European Surgical Research

JF - European Surgical Research

SN - 0014-312X

IS - 1

ER -